Trials / Completed
CompletedNCT00309101
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 16 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus | Oral |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2006-03-31
- Last updated
- 2009-06-03
Locations
9 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00309101. Inclusion in this directory is not an endorsement.